データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
CytoSorbents Reported Strong Q4 Results, Says D. Boral Capital
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth
Cytosorbents Price Target Maintained With a $10.00/Share by D. Boral Capital
Cytosorbents Is Maintained at Buy by D. Boral Capital
CytoSorbents Sees Higher Product Revenue, Weak Margin In Q4; Stock Down
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue